Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

49 projects found matching your search criteria :

  1. Smart Multiscale Encapsulation System: Hydrogel Macrocapsules with LbL Nanoparticles for Colorectal Cancer Treatment

    Call: PRELUDIUM 24 , Panel: ST11

    Principal investigator: Joanna Irena Szechyńska

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  2. Artificial intelligence in predicting treatment outcomes of abdominal cancers – implementation of machine learning and d...

    Call: SONATINA 9 , Panel: NZ7

    Principal investigator: dr Krzysztof Bartnik

    Politechnika Warszawska

  3. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Call: SONATINA 9 , Panel: NZ6

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  4. Developing histone deacetylase-inhibiting hybrid analogs of pleurocidin and their potential in the treatment of HPV-indu...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr hab. Ewelina Piktel

    Uniwersytet Medyczny w Białymstoku

  5. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  6. Novel aspects of the mechanisms of vascular toxicity of tyrosine kinase inhibitors: studies on their proinflammatory act...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr Tomasz Krzysztof Prajsnar

    Uniwersytet Jagielloński, Wydział Biologii

  7. Advanced statistical and deep learning models to predict cancer risk and support treatment decisions

    Call: SONATA BIS 13 , Panel: NZ2

    Principal investigator: dr Michał Marczyk

    Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

  8. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

  9. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Błażej Rubiś

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  10. Multifunctional emulsion-based transporters for personalised cancer treatment

    Call: OPUS 25 , Panel: ST8

    Principal investigator: prof. Ewa Dłuska

    Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

  11. Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Ryszard Józef Ostaszewski

    Instytut Chemii Organicznej Polska Akademia Nauk

  12. Precise molecular characterization of circulating tumour cells in patients with triple negative breast cancer using high...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Stefano Volinia

    Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

  13. Histone demethylase inhibitors as chemosensitivity modulators in the treatment of head and neck squamous cell carcinoma

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Dawid Dariusz Dorna

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  14. Use of comparative oncology approach to dissect the PD-1 intrinsic signalling in osteosarcoma. Can dog be the key for ne...

    Call: PRELUDIUM 21 , Panel: NZ1

    Principal investigator: Katarzyna Joanna Dziubek

    Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

  15. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Anna Katarzyna Florczak-Substyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  16. Targeting of HSF1 as a therapeutic approach to inhibit the progression of hormone-dependent breast cancer.

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr Natalia Vydra

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  17. Improvement of therapeutic safety of parenteral nutrition in cancer patients - the interplay between supportive drugs an...

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: Szymon Tomczak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  18. New type of analogs and conjugates of folic acid with potential therapeutic applicaton in treatment of hormone-dependent...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Olga Ciupak

    Politechnika Gdańska, Wydział Chemiczny

  19. Blocking the TNF-TNFR2 interactions as a novel approach to the ovarian carcinoma treatment

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Sylwia Anna Rodziewicz-Motowidło

    Uniwersytet Gdański, Wydział Chemii

  20. Exploring new roles for ADAR1 in cancer; generation of novel neoantigens, links with p53 and the effects of cancer treat...

    Call: WEAVE-UNISONO , Panel: NZ2

    Principal investigator: dr Małgorzata Kurkowiak

    Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

  21. Tryptophan Metabolites and their Metal Complexes as new drugs for Colorectal Cancer Treatment and Human Gut Microbiota R...

    Call: OPUS 20 , Panel: ST4

    Principal investigator: prof. Beata Izabella Godlewska-Żyłkiewicz

    Uniwersytet w Białymstoku, Wydział Chemii

  22. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr hab. Janusz Marcin Dąbrowski

    Uniwersytet Jagielloński, Wydział Chemii

  23. Modulation of exosome production to support anti-cancer treatment

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: dr Liliana Monika Czernek

    Centrum Badań Molekularnych i Makromolekularnych PAN

  24. Curcuminoid-polyphenol conjugates as potential therapeutics for urinary system cancer treatment

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  25. Quantitative analysis of ultrasound scattered in the tissue. Application in assessing tumor response to chemotherapy in ...

    Call: OPUS 18 , Panel: ST7

    Principal investigator: prof. Jerzy Litniewski

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  26. The [60]fullerene-based theranostic agent for pancreatic cancers treatment and diagnosis

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: dr Maciej Michał Serda

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

  27. Liposomal berberine and anti-CD47 antibody as an effective therapy for the treatment of colorectal cancer

    Call: PRELUDIUM 17 , Panel: NZ5

    Principal investigator: dr Martyna Maria Mianowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

  28. Development of new and more efficient treatment against mesothelioma utilizing oncolytic adenovirus armed with ICOS liga...

    Call: SONATINA 3 , Panel: NZ7

    Principal investigator: dr Łukasz Kuryk

    Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

  29. Hypoxia in combinatory treatment of murine pancreatic tumor

    Call: OPUS 15 , Panel: NZ5

    Principal investigator: dr Martyna Krzykawska-Serda

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  30. New Hexokinase II inhibitors, in search of innovative therapeutic approaches to cancer treatment

    Call: PRELUDIUM 14 , Panel: NZ7

    Principal investigator: Mateusz Dawid Tomczyk

    Politechnika Śląska, Wydział Chemiczny

  31. Preparation and investigation of multifunctional biomaterials based on nanoapatites for possible application in bone tum...

    Call: PRELUDIUM 14 , Panel: ST5

    Principal investigator: dr Paulina Teresa Sobierajska

    Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

  32. Combined urinary bladder cancer treatment with isothiocyanate-derived mercapturic acids and microtubule assembly modulat...

    Call: SONATA 13 , Panel: NZ7

    Principal investigator: dr Mateusz Psurski

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  33. Molecular mechanism of action and therapeutic effect of 5-aza-2'-deoxycytidine and topoisomerase inhibitors combination ...

    Call: OPUS 13 , Panel: NZ5

    Principal investigator: dr hab. Wojciech Kałas

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  34. Identification of the mechanism of antineoplastic activity of metformin, as an experimental approach to improve cancer t...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Jerzy Aleksander Pałka

    Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  35. Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the colorectal cancer treatment

    Call: OPUS 12 , Panel: NZ5

    Principal investigator: prof. Adam Janusz Dziki

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  36. Effectiveness of anticancer activity of DMU-214 (3'-hydroxy-3,4,5,4'-tetrametoxystilbene) in personalized treatment for ...

    Call: SONATA 12 , Panel: NZ7

    Principal investigator: dr hab. Hanna Helena Piotrowska-Kempisty

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  37. Association of selected, inherited genetic factors with the effectiveness of treatment in head and neck squamous cell ca...

    Call: OPUS 12 , Panel: NZ5

    Principal investigator: dr hab. Dorota Monika Butkiewicz

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  38. Emerging spectroscopic technologies in diagnosis and treatment of cancer by Raman-IR-SNOM-AFM-femtosecond scpectroscopy-...

    Call: OPUS 10 , Panel: ST4

    Principal investigator: prof. Halina Abramczyk

    Politechnika Łódzka, Wydział Chemiczny

  39. Co-dependence of cell-to-cell metabolite shuttles and macromolecular organization of metabolism in norm and pathology. Q...

    Call: OPUS 10 , Panel: NZ1

    Principal investigator: prof. Dariusz Stanisław Rakus

    Uniwersytet Wrocławski, Wydział Nauk Biologicznych

  40. AP-1 : a novel player in the regulation of Senescence Associated Secretory Phenotype of cancer cells

    Call: PRELUDIUM 10 , Panel: NZ3

    Principal investigator: Anna Aneta Strzeszewska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  41. SLC6A14 - an amino acid transporter upregulated in cancer: Role of chaperone proteins in transporter exit from endoplasm...

    Call: OPUS 10 , Panel: NZ3

    Principal investigator: prof. Katarzyna Anna Nałęcz

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  42. Description of platelets role in metastasis and evaluation of anti-platelet treatment efficacy in mice model of metastat...

    Call: PRELUDIUM 8 , Panel: NZ7

    Principal investigator: Elżbieta Buczek

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  43. Study on the mechanism of cancer cell growth inhibition by synergistic activation of p53 protein caused by combined trea...

    Call: OPUS 6 , Panel: NZ5

    Principal investigator: dr hab. Marek Rusin

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

  44. Study of the role of follicle stimulating hormone and its receptor in growth and putative treatment strategies for prost...

    Call: PRELUDIUM 6 , Panel: NZ5

    Principal investigator: Joanna Stelmaszewska

    Uniwersytet Medyczny w Białymstoku, Wydział Lekarski z Oddziałem Stomatologii i Oddziałem Nauczania w Języku Angielskim

  45. The role of endogenous opioid system in the pathogenesis and treatment of inflammatory bowel diseases and colitis-associ...

    Call: PRELUDIUM 6 , Panel: NZ7

    Principal investigator: dr Marta Zielińska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  46. Development of hyphenated analytical (capillary electrophoresis-inductively coupled plasma mass spectrometry) methodolog...

    Call: PRELUDIUM 6 , Panel: ST4

    Principal investigator: Magdalena Matczuk

    Politechnika Warszawska, Wydział Chemiczny

  47. The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance...

    Call: PRELUDIUM 3 , Panel: NZ5

    Principal investigator: dr Magdalena Milczarek

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  48. Influence of individual genetic host factors, associated with DNA damage, antioxidant defence, metastasis and angiogenes...

    Call: OPUS 3 , Panel: NZ5

    Principal investigator: dr hab. Dorota Butkiewicz

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Centrum Onkologii Instytut im. M Skłodowskiej–Curie Oddział w Gliwicach

  49. Effects of receptor action of L- and D-Lactate on cervical cancer cells. Lactate modulation of cell DNA repair response ...

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: dr Waldemar Wagner

    Instytut Biologii Medycznej PAN